D. Spanopoulos

First name

D.

Last name

Spanopoulos

Spanopoulos, D., Barrett, B., Busse, M., Roman, T., & Poole, C. (2018). Prescription of DPP-4 Inhibitors to Patients With Adult Type 2 Diabetes Mellitus and Creatinine Clearance>50 mL/min: The UK Primary Care Experience. Clin Ther. http://doi.org/10.1016/j.clinthera.2018.06.002

View

Spanopoulos, D., Barrett, B., Busse, M., Roman, T., & Poole, C. (2018). Prescription of DPP-4 Inhibitors to Type 2 Diabetes Mellitus Patients With Renal Impairment: A UK Primary Care Experience. Clin Ther. http://doi.org/10.1016/j.clinthera.2017.11.009

View

Spanopoulos, D., Okhai, H., Zaccardi, F., Tebboth, A., Barrett, B., Busse, M., et al. (2019). Temporal variation of renal function in people with type 2 diabetes mellitus: a retrospective UK Clinical Practice Research Datalink cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.13734

View

Spanopoulos, D., Busse, M., Webb, J., Tebboth, A., Gollop, N. D., & Marcus, M. W. (2019). DPP-4 Inhibitor Dose Selection According to Manufacturer Specifications: A Contemporary Experience From UK General Practice. Clin Ther. http://doi.org/10.1016/j.clinthera.2019.05.010

View

Webb, J., Mount, J., von Arx, L. B., Rachman, J., Spanopoulos, D., Wood, R., et al. (2021). Cardiovascular risk profiles: A cross-sectional study evaluating the generalisability of the glucagon-like peptide-1 receptor agonist cardiovascular outcome trials Rewind, Leader and Sustain-6 to the real-world type 2 diabetes population in the UK. Diabetes Obes Metab. http://doi.org/10.1111/dom.14580

View